Search by Drug Name or NDC
NDC 51662-1213-01 25% Dextrose Infant 250 mg/mL Details
25% Dextrose Infant 250 mg/mL
25% Dextrose Infant is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by HF Acquisition Co. LLC, DBA Health First. The primary component is DEXTROSE MONOHYDRATE.
Product Information
NDC | 51662-1213 |
---|---|
Product ID | 51662-1213_ef6a78fb-553f-a83e-e053-2995a90a6164 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | 25% Dextrose Infant |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | 25% Dextrose Infant |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 250 |
Active Ingredient Units | mg/mL |
Substance Name | DEXTROSE MONOHYDRATE |
Labeler Name | HF Acquisition Co. LLC, DBA Health First |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA019445 |
Listing Certified Through | 2024-12-31 |
Package
NDC 51662-1213-01 (51662121301)
NDC Package Code | 51662-1213-1 |
---|---|
Billing NDC | 51662121301 |
Package | 1 SYRINGE, PLASTIC in 1 CARTON (51662-1213-1) / 10 mL in 1 SYRINGE, PLASTIC |
Marketing Start Date | 2018-08-19 |
NDC Exclude Flag | N |
Pricing Information | N/A |